Related Experiment Video
Updated: Jul 7, 2026
09:35
Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection
Published on: February 2, 2018
Gene therapy for haemophilia.
Samuel L Murphy1, Katherine A High
1Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
British Journal of Haematology
|February 16, 2008
Summary
Gene therapy aims to replace faulty genes for lifelong disease cure. While showing promise for hemophilia treatment, challenges remain in achieving sustained efficacy and overcoming hidden barriers.
Area of Science:
- Biotechnology
- Genetics
- Medical Science
Background:
- Gene therapy seeks to correct genetic defects for permanent disease elimination.
- Early hemophilia gene transfer trials demonstrated safety but lacked efficacy.
- Advancements in vector design and delivery systems have improved preclinical outcomes.
Purpose of the Study:
- To review progress and challenges in gene therapies for hemorrhagic disorders.
- To focus on gene therapy approaches nearing or in clinical application.
Main Methods:
- Review of clinical trials and preclinical studies on gene transfer for hemophilia.
- Analysis of vector plasmid and delivery system reengineering.
- Evaluation of outcomes from recent clinical trials.
Main Results:
- Initial hemophilia gene therapy trials showed good safety but no efficacy.
- Improved outcomes observed in animal models after vector reengineering.
- Recent trials demonstrated transient efficacy in hemophilia B, revealing new barriers.
Conclusions:
- Gene therapy for hemophilia has progressed significantly but faces hurdles.
- Transient efficacy and previously unrecognized barriers impede long-term success.
- Further research is needed to overcome challenges for widespread clinical application.
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:59CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
00:49What is Genetic Engineering?
Overview